Michael Burry Increases Stake in Molina Healthcare; Fundamentals Still Face Near-Term Tests

What happened

Michael Burry's Scion Asset Management has increased its position in Molina Healthcare, as reported by GuruFocus, signaling potential longer-term confidence in the health insurer. This move comes after Molina's Q2 2026 results, which saw Marketplace medical care ratio rise to 88.9% and membership fall sharply, triggering a sharp selloff from above $230 to near $200. Our DeepValue master report rates MOH as WAIT, with a base-case implied value of $215, but key near-term risks remain around Marketplace repricing and the Florida Medicaid launch in Q4 2026. Burry's increased stake may reflect a contrarian bet on Molina's Medicaid contract wins in Florida, Georgia, Texas, and Illinois eventually offsetting exchange losses. However, the market is still discounting the ACA cleanup story, and the stock currently trades near fair value with limited margin of safety.

Implication

Over a 12-18 month horizon, if Burry's thesis proves correct that Medicaid growth outweighs Marketplace drag, the stock could re-rate toward the bull case of $245. Conversely, if Marketplace MCR fails to improve or Florida start-up losses exceed the disclosed $1.50 EPS, the bear case of $160 becomes more likely. Given the balanced risk/reward at $200, investors should await clearer evidence of MCR improvement or a better entry near $175 before adding exposure.

Thesis delta

The underlying investment thesis for Molina Healthcare remains unchanged by Burry's increased stake; the fundamental earnings tests are still Marketplace MCR improvement and Florida implementation. Burry's action adds a notable holder and may indicate that a respected value investor sees undervaluation, but that alone does not alter the WAIT rating. We maintain our stance that buying now pays off only if Q3-Q4 2026 show operational progress.